Published on in Vol 11, No 2 (2022): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/32918, first published .
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial

Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial

Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial

Andrew Farmer   1 , DM ;   Louise Jones   1 , DPhil ;   Nikki Newhouse   1 , BA, PGDip, PhD ;   Cassandra Kenning   2 , PhD ;   Nicola Williams   1 , MSc ;   Yuan Chi   3 , BEng, PhD ;   Y Kiera Bartlett   4 , PhD ;   Catrin Plumpton   5 , PhD ;   Jenny McSharry   6 , PhD ;   Rachel Cholerton   4 , PhD ;   Emily Holmes   5 , BA, MSc, PhD ;   Stephanie Robinson   1 , JD ;   Julie Allen   1 , BA ;   Bernard Gudgin   7 , PhD ;   Carmelo Velardo   3, 8 , MSc, PhD ;   Heather Rutter   1, 9 , BSc ;   Rob Horne   10 , PhD ;   Lionel Tarassenko   3 , DPhil ;   Veronika Williams   11 , BSc, RN, PhD ;   Louise Locock   12 , MPhil, PhD ;   Rustam Rea   13, 14 , DM ;   Ly-Mee Yu   1 , MSc, DPhil ;   Dyfrig Hughes   5 , PhD ;   Peter Bower   2 , BSc, PhD ;   David French   4 , BSc, MSc, PhD

1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

2 Centre for Primary Care and Health Services Research, University of Manchester, Manchester, United Kingdom

3 Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom

4 Manchester Centre for Health Psychology, University of Manchester, Manchester, United Kingdom

5 Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, United Kingdom

6 Health Behaviour Change Research Group, School of Psychology, National University of Ireland Galway, Galway, Ireland

7 Patient Advocate, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

8 Sensyne Health plc, Oxford, United Kingdom

9 Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom

10 Centre for Behavioural Medicine, University College London, London, United Kingdom

11 School of Nursing, Nipissing University, North Bay, ON, Canada

12 Health Services Research Unit, University of Aberdeen, Aberdeen, United Kingdom

13 Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom

14 NIHR Oxford Biomedical Research Centre, Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom

Corresponding Author:

  • Andrew Farmer, DM
  • Nuffield Department of Primary Care Health Sciences
  • University of Oxford
  • Gibson Building
  • Radcliffe Observatory Quarter
  • Oxford, OX2 6GG
  • United Kingdom
  • Phone: 44 1865 617942
  • Email: andrew.farmer@phc.ox.ac.uk